Association of Arachidonic Acid–Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple Sclerosis
Jelle Y. Broos(Leiden University), Gijs Kooij(Amsterdam Neuroscience), Eva Strijbis(Amsterdam University Medical Centers), Floor C. Loonstra(Leiden University), Mariam Gouda(Leiden University), Martin Giera(Leiden University Medical Center), Marieke Heijink(Leiden University), Lodewijk R. J. de Ruiter(Leiden University), Menno M. Schoonheim(Amsterdam Neuroscience), Charlotte E. Teunissen(Amsterdam Neuroscience), Joep Killestein(Amsterdam UMC Location Vrije Universiteit Amsterdam), Helga E. de Vries(Amsterdam Neuroscience), Wing Hee Fung(Amsterdam Neuroscience), Bernard M.J. Uitdehaag(Amsterdam UMC Location Vrije Universiteit Amsterdam)
Cited by 24
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
|Multiple Sclerosis Journal|2020|2.5k
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
|Alzheimer s & Dementia|2024|2.3k
Loss of ‘Small-World’ Networks in Alzheimer's Disease: Graph Analysis of fMRI Resting-State Functional Connectivity
|PLoS ONE|2010|621
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
|Alzheimer s & Dementia|2022|589